Skip to main content

Day: July 5, 2023

Ceapro to Participate in the Virtual Investor Summer Spotlight Series

Live moderated video webcast on Wednesday, July 12th at 1:00 PM ET EDMONTON, Alberta, July 05, 2023 (GLOBE NEWSWIRE) — Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro” or the “Company”), a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, announced today that Gilles Gagnon, President and Chief Executive Officer of Ceapro and Dr. Vincent W. Li, Chief Operating Officer and Scientific Director of the Angiogenesis Foundation will participate in the Virtual Investor Summer Spotlight Series on Wednesday, July 12, 2023 at 1:00 PM ET. A live video webcast of the presentation will be available on the Events page of the Investors section of the Company’s website (ceapro.com). A webcast replay will be available two hours following the live presentation...

Continue reading

Aeterna Zentaris to Participate in the Virtual Investor Summer Spotlight Series

Live moderated video webcast on Thursday, July 13th at 10:00 AM ET TORONTO, ONTARIO, July 05, 2023 (GLOBE NEWSWIRE) — Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products, today announced that Dr. Klaus Paulini, Chief Executive Officer and Eckhard Guenther, PhD, Managing Director and SVP, Business Development of Aeterna Zentaris, will participate in the Virtual Investor Summer Spotlight Series on Wednesday, July 13, 2023, at 10:00 AM ET. A live video webcast of the presentation will be available on the Events page of the Investors section of the Company’s website (zentaris.com). A webcast replay will be available two hours following the live presentation and will be accessible...

Continue reading

NEO Battery Materials Enters Into Binding Agreement with Preferred Contractor for South Korean Commercial Plant Construction

TORONTO, July 05, 2023 (GLOBE NEWSWIRE) — (TSXV: NBM) (OTCQB: NBMFF)Entered Into Binding Agreement with Preferred Contractor for South Korean Commercial Plant To Initiate Ground Break in August 2023 with Targeted Completion by First Half of 2024 for Plant Commissioning and Mass Production ValidationInitial Capacity of 240 Tons Per Year with Final Scale-Up to 5,000 Tons Per Year Will Supply Up to 3 Million EVs Across South Korea, the U.S., and EuropeNEO Battery Materials Ltd. (“NEO” or the “Company”), a low-cost silicon anode materials developer that enables longer-running, rapid-charging lithium-ion batteries, is pleased to announce that the Company has entered into a binding agreement with its preferred contractor (“Contractor”) and expects the construction of the South Korean Commercial Plant to initiate next month in...

Continue reading

Sportradar Wins Major Bid for CONMEBOL Rights as Official Global Betting Partner

The multi-year exclusive agreement covers worldwide rights for CONMEBOL Libertadores, CONMEBOL Sudamericana and CONMEBOL Recopa to bring competitions to fans all over the world and boost fan engagement  Latest deal adds to growing and diverse portfolio of rights around the world  SÃO PAULO, Brazil and ST. GALLEN, Switzerland, July 05, 2023 (GLOBE NEWSWIRE) — Following a highly competitive selection process, the South American Football Confederation (CONMEBOL) today announces that it has selected Sportradar (NASDAQ: SRAD) as the successful bidder for exclusive global audio and video (AV) and betting data rights, that will enhance the accessibility and engagement of South American football for a broader global audience. CONMEBOL, the governing body of ten National Soccer Associations in South America, entertains millions of fans...

Continue reading

Abacus Life Begins Trading on Nasdaq Under New Ticker Symbol “ABL”

Listing Follows Completion of Business Combination with East Resources Acquisition Company ORLANDO, Fla. and BOCA RATON, Fla., July 05, 2023 (GLOBE NEWSWIRE) — Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a leading buyer of life insurance policies and vertically integrated alternative asset manager specializing in specialty insurance products, announced that its common stock and warrants will begin trading on Nasdaq today, July 5, 2023, under the symbols “ABL” and “ABLLW”, respectively. Abacus’s listing follows the previously announced completion of its business combination with East Resources Acquisition Company (“ERES”). Abacus’s management team will participate in an opening bell ceremony at Nasdaq on July 13, 2023 at 9:30 am ET to celebrate the public listing. “We are excited to celebrate this important milestone...

Continue reading

AIM ImmunoTech to Participate in the Virtual Investor Summer Spotlight Series

Live moderated video webcast on Wednesday, July 12th at 11:00 AM ET OCALA, Fla., July 05, 2023 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders, and viral diseases, including COVID-19, the disease caused by the SARS-CoV-2 virus, today announced that Thomas K. Equels, MS JD, Chief Executive Officer of AIM ImmunoTech and Dr. Christopher McAleer, Scientific Officer at AIM ImmunoTech will participate in the Virtual Investor Summer Spotlight Series on Wednesday, July 12, 2023 at 11:00 AM ET. A live video webcast of the presentation will be available on the Events page of the Company’s website (aimimmuno.com). A webcast replay will be available two hours following the...

Continue reading

GCANRx Announces Approval of Phase II Clinical Trial to Treat Autism Related Spectrum Disorders

BALTIMORE, July 05, 2023 (GLOBE NEWSWIRE) — Greater Cannabis Company, Inc. (“GCANRx” or the “Company”) (OTC: GCAN) a publicly traded biopharmaceutical company pioneering development of next generation therapeutics is pleased to announce that it has been granted final approval for its double blind, placebo controlled Phase II Clinical Trial for the treatment of Autism Spectrum Disorder (ASD) from the Israel Ministry of Health. The Company previously announced that it is planning to conduct a Phase II clinical trial spearheaded by principal investigator, Dr. Adi Aran, M.D., to study the safety and efficacy of its neuroprotective cannabinoid therapeutic to treat autism related spectrum disorders (ASD) and other neuropsychiatric disorders such as Parkinson’s Disease, Alzheimer’s Disease, schizophrenia, and epilepsy. The primary objective...

Continue reading

Metro Compactor Service acquires Miller Waste Solutions Group

Acquisition includes waste and recycling equipment service and manufacturing division of Miller Waste Systems TORONTO, July 05, 2023 (GLOBE NEWSWIRE) — Metro Compactor Service, Canada’s leading expert in waste and recycling equipment service and supply for over 40 years, is expanding its operations and further scaling up in Ontario with the acquisition of Miller Waste Solutions Group. The company, (formerly WSG), is Miller Waste Systems’ division that focuses on the service-and-manufacturing of waste-and-recycling-equipment. Today’s acquisition will expand Metro’s capabilities in the province, allowing the company to meet growing demand through a larger fleet of service vehicles and additional service technicians. “With an increased fleet and more techs in the field, we will now be able to service our customers better, faster...

Continue reading

Significant Tantalum Anomalies Reported in the Till of the Maskwa Property at Eeyou Istchee Baie-James, Québec

Photo PhotoMONTREAL, July 05, 2023 (GLOBE NEWSWIRE) — The directors of Sirios Resources Inc. (TSX-V: SOI) are pleased to announce the presence of significant tantalum anomalies in till samples from the survey carried out on its Maskwa property in 2020. In this 97-sample survey, three anomalies were identified, each with significant grain counts exceeding one hundred tantalum bearing mineral grains. A total of 3,310 grains, were observed, mainly Columbo-Tantalites (niobium and tantalum oxide mineral), averaging 34 grains per sample with a maximum of 179 grains (see map below). These observations come from the 97 heavy mineral concentrates processed by the ARTGold method, an automated mineral detection scanning by electron microscope (SEM), a technology exclusive to IOS Services Geoscientifiques Inc. of Saguenay, Quebec. Columbo-Tantalite...

Continue reading

Invesco Ltd: Form 8.3 – Alfa Financial Software Holdings PLC

FORM 8.3 PUBLIC DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1. KEY INFORMATION     (a) Full name of discloser: Invesco Ltd.  (b) Owner or controller of interests and short positions disclosed, if different from 1(a):The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.    (c) Name of offeror/offeree in relation to whose relevant securities this form relates:Use a separate form for each offeror/offeree Alfa Financial Software Holdings PLC  (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:    (e) Date position held/dealing undertaken:For an opening position disclosure, state the latest practicable...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.